Medical imaging technology company Polarean Imaging has received an additional research unit order for a xenon polariser ‘9820’, it announced on Monday.
The AIM-traded firm said the system would be installed at the Center for Pulmonary Imaging Research at the Cincinnati Children’s Medical Center (CCHMC).
Polarean holds a Small Business Innovation Research grant with the Cincinnati Children’s Center, awarded by the National Heart, Lung and Blood Institute (NHLBI) in April 2017.
It described CCHMC as a non-profit academic medical centre, and was one of its longest key clinical collaborators.
Polarean said a key focus of the collaboration was to lead the field of paediatric pulmonary imaging through advanced imaging techniques and multi-nuclear capabilities, including hyperpolarised 129Xenon gas.
“We are pleased to announce the ordering of the latest model of our xenon polariser from the CCHMC,” said chief executive officer Richard Hullihen.
“We are delighted to be able to support their exceptional programme for advancing non-invasive hyperpolarised noble gas MR imaging in paediatric research.
“The CCHMC have made significant progress in their breakthrough efforts in early detection, therapy development, evaluation and management and we believe our partnership can help them improve the outcomes for the most vulnerable of patients.”
At 0954 BST, shares in Polarean Imaging were up 0.2% at 55.11p.
